Literature DB >> 25365069

Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation.

A C Mamez1, L Souchet1, D Roos-Weil1, M Uzunov1, A L Brun2, C Algrin1, V Leblond1, S Nguyen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25365069     DOI： 10.1038/bmt.2014.243

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine.

Authors:  Lei Yuan; Lu Sun; Jian Bo; Ying Zhou; Hong-hua Li; Li Yu; Chun-ji Gao
Journal:  Ann Transplant       Date:  2011 Jul-Sep       Impact factor: 1.530

2.  Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

Authors:  A Dodero; F Spina; F Narni; F Patriarca; I Cavattoni; F Benedetti; F Ciceri; D Baronciani; R Scimè; E Pogliani; A Rambaldi; F Bonifazi; S Dalto; B Bruno; P Corradini
Journal:  Leukemia       Date:  2011-09-09       Impact factor: 11.528

3.  Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.

Authors:  Junya Kanda; Masakatsu Hishizawa; Atae Utsunomiya; Shuichi Taniguchi; Tetsuya Eto; Yukiyoshi Moriuchi; Ryuji Tanosaki; Fumio Kawano; Yasushi Miyazaki; Masato Masuda; Koji Nagafuji; Masamichi Hara; Minoko Takanashi; Shunro Kai; Yoshiko Atsuta; Ritsuro Suzuki; Takakazu Kawase; Keitaro Matsuo; Tokiko Nagamura-Inoue; Shunichi Kato; Hisashi Sakamaki; Yasuo Morishima; Jun Okamura; Tatsuo Ichinohe; Takashi Uchiyama
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

4.  Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Rafael F Duarte; Carmen Canals; Francesco Onida; Ian H Gabriel; Reyes Arranz; William Arcese; Augustin Ferrant; Guido Kobbe; Franco Narni; Giorgio Lambertenghi Deliliers; Eduardo Olavarría; Norbert Schmitz; Anna Sureda
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

5.  Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Charalampia Kyriakou; Carmen Canals; Jürgen Finke; Guido Kobbe; Jean-Luc Harousseau; Hans-Jochem Kolb; Nicolas Novitzky; Anthony H Goldstone; Anna Sureda; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

6.  Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.

Authors:  Shinichi Kako; Koji Izutsu; Kumi Oshima; Hiroyuki Sato; Yoshinobu Kanda; Toru Motokura; Shigeru Chiba; Mineo Kurokawa
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

7.  Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.

Authors:  A M Marmont; F Gualandi; M T Van Lint; A Bacigalupo
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

8.  Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.

Authors:  Steven Le Gouill; Noel Milpied; Agnès Buzyn; Régis Peffault De Latour; Jean-Paul Vernant; Mohamad Mohty; Marie-Pierre Moles; Krimo Bouabdallah; Claude-Eric Bulabois; Jehan Dupuis; Bernard Rio; Nicole Gratecos; Ibrahim Yakoub-Agha; Michel Attal; Olivier Tournilhac; Didier Decaudin; Jean-Henry Bourhis; Didier Blaise; Christelle Volteau; Mauricette Michallet
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544

9.  High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Charalampia Kyriakou; Carmen Canals; Anthony Goldstone; Dolores Caballero; Bernd Metzner; Guido Kobbe; Hans-Jochem Kolb; Joachim Kienast; Peter Reimer; Jurgen Finke; Gunnar Oberg; Ann Hunter; Niklas Theorin; Anna Sureda; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

10.  Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

Authors:  Paolo Corradini; Anna Dodero; Francesco Zallio; Daniele Caracciolo; Marco Casini; Marco Bregni; Franco Narni; Francesca Patriarca; Mario Boccadoro; Fabio Benedetti; A Rambaldi; Alessandro M Gianni; Corrado Tarella
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
  10 in total
  5 in total

1.  Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation.

Authors:  Natasha Kekre; Haesook T Kim; Gita Thanarajasingam; Philippe Armand; Joseph H Antin; Corey Cutler; Sarah Nikiforow; Vincent T Ho; John Koreth; Edwin P Alyea; Robert J Soiffer
Journal:  Haematologica       Date:  2015-06-18       Impact factor: 9.941

2.  Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  A C Mamez; V Lévy; P Chevallier; D Blaise; S Vigouroux; A Xhaard; N Fegueux; N Contentin; Y Beguin; N Ifrah; C E Bulabois; F Suarez; I Yakoub-Agha; P Turlure; E Deconink; T Lamy; J Y Cahn; A Huynh; S Maury; L M Fornecker; M Ouzegdouh; J O Bay; G Guillerm; N Maillard; M Michallet; J V Malfuson; J H Bourhis; F Rialland; R Oumedaly; C Jubert; V Leblond; M Boubaya; M Mohty; S Nguyen
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

3.  Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  Anne-Claire Mamez; Axelle Dupont; Didier Blaise; Patrice Chevallier; Edouard Forcade; Patrice Ceballos; Mohamad Mohty; Felipe Suarez; Yves Beguin; Regis Peffault De Latour; Marie-Thérèse Rubio; Olivier Tournilhac; Stéphanie Nguyen
Journal:  J Hematol Oncol       Date:  2020-05-19       Impact factor: 17.388

Review 4.  Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Wen-Rong Huang; Dai-Hong Liu
Journal:  Chin Med J (Engl)       Date:  2018-09-05       Impact factor: 2.628

5.  [Clinical outcomes of peripheral blood stem cell transplantation for aggressive peripheral T-cell lymphoma].

Authors:  W R Huang; Z Y Gu; H H Li; J Bo; S H Wang; F Li; X N Gao; L P Dou; Y Zhao; Y Jing; H Y Zhu; Q S Wang; L Yu; C J Gao; D H Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.